Press release
Looking at Growing Demand of Top 10 Cancer Drugs: Market Size Is Anticipated to Reach A Valuation Of $129,948 million by 2026
Allied Market Research recently said Cancer drugs, also known as anticancer drugs, are medications that are used to treat cancer. These drugs work by targeting and killing cancer cells, slowing down or stopping their growth, or preventing them from spreading to other parts of the body. Cancer drugs can be administered in several ways, including orally, intravenously, or through injection. The global top 10 cancer drugs market sales was valued at $63,619 million in 2018 and is expected to reach $129,948 million by 2026, registering a CAGR of 9.8% from 2019 to 2026.โฆ ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/request-sample/6225
The top 10 cancer drugs, ranked by global sales revenue in 2021, are:
1. Keytruda (pembrolizumab) - used to treat various types of cancer, including lung cancer, melanoma, and bladder cancer.
2. Revlimid (lenalidomide) - used to treat multiple myeloma and certain types of lymphoma.
3. Opdivo (nivolumab) - used to treat various types of cancer, including lung cancer, melanoma, and kidney cancer.
4. Imbruvica (ibrutinib) - used to treat various types of cancer, including chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's macroglobulinemia.
5. Rituxan (rituximab) - used to treat various types of cancer, including non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis.
6. Herceptin (trastuzumab) - used to treat breast cancer and stomach cancer that overexpress the HER2 protein.
7. Avastin (bevacizumab) - used to treat various types of cancer, including colorectal cancer, lung cancer, and glioblastoma.
8. Ibrance (palbociclib) - used to treat breast cancer that is hormone receptor-positive and HER2-negative.
9. Revlimid + Rituxan (lenalidomide + rituximab) - used to treat follicular lymphoma and marginal zone lymphoma.
10. Tagrisso (osimertinib) - used to treat non-small cell lung cancer that has a specific genetic mutation.
It is important to note that the use of cancer drugs is highly dependent on the type and stage of cancer, as well as other individual patient factors, and treatment plans are typically developed in consultation with a medical oncologist.
โฆ ๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐ ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ) @
https://www.alliedmarketresearch.com/checkout-final/5426e41c2eb5263e79a39b4689f6c50e
๐๐บ๐ฝ๐ผ๐ฟ๐๐ฎ๐ป๐ ๐๐ฒ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฃ๐น๐ฎ๐๐ฒ๐ฟ๐ ๐๐ฟ๐ฒ -
โข AbbVie Inc.,
โข Astellas Pharma Inc.,
โข AstraZeneca PLC,
โข Bristol-Myers Squibb Company,
โข Celgene Corporation,
โข F. Hoffmann-La Roche Ltd.,
โข Johnson & Johnson (Janssen Global Services, LLC,),
โข Merck & Co., Inc.,
โข Novartis AG, and
โข Pfizer Inc.
There are many different types of cancer drugs, including chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormone therapy drugs. Chemotherapy drugs are cytotoxic, meaning they work by killing rapidly dividing cancer cells, but they can also harm healthy cells in the body, resulting in side effects such as nausea, vomiting, and hair loss. Targeted therapy drugs work by targeting specific molecules or proteins that are involved in the growth and spread of cancer cells, while immunotherapy drugs work by boosting the body's immune system to fight cancer. Hormone therapy drugs are used to treat cancers that are hormone-sensitive, such as breast and prostate cancer.
๐๐ฒ๐ ๐๐ถ๐ป๐ฑ๐ถ๐ป๐ด๐ ๐ผ๐ณ ๐ง๐ต๐ฒ ๐ฆ๐๐๐ฑ๐ -
โข Revlimid occupied 15.22% share of the global top 10 cancer drugs sales in 2018.
โข Keytruda is anticipated to grow at the highest rate during the analysis period.
โข The Europe cancer drugs accounted for 21.21% share of the global top 50 cancer drugs sales in 2018.
โฆ ๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/6225
๐๐ฒ๐ผ๐ด๐ฟ๐ฎ๐ฝ๐ต๐ถ๐ฐ ๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ ๐๐ผ๐๐ฒ๐ฟ๐ฒ๐ฑ ๐ถ๐ป ๐๐ต๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ -
The Top 10 Cancer Drugs Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
โข North America (USA and Canada)
โข Europe (UK, Germany, France and the rest of Europe)
โข Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
โข Latin America (Brazil, Mexico, and the rest of Latin America)
โข Middle East and Africa (GCC and rest of the Middle East and Africa)
๐๐ฟ๐ฒ๐พ๐๐ฒ๐ป๐๐น๐ ๐๐๐ธ๐ฒ๐ฑ ๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป๐?
Q1. What is the total market value of Top 10 Cancer Drugs Market report?
Q2. Which are the top companies hold the market share in Top 10 Cancer Drugs Market?
Q3. Which is the most influencing segment growing in the Top 10 Cancer Drugs Market report?
Q4. What would be forecast period in the market report?
Q5. What is the market value of Top 10 Cancer Drugs Market in 2020?
๐๐ผ๐ป๐๐ฎ๐ฐ๐:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
๐๐ฏ๐ผ๐๐ ๐จ๐ -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Looking at Growing Demand of Top 10 Cancer Drugs: Market Size Is Anticipated to Reach A Valuation Of $129,948 million by 2026 here
News-ID: 2948400 • Views: โฆ
More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collectโฆ

Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growthโฆ

Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil โฆ
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strictโฆ

Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of โฆ
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise inโฆ
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by โฆ
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingโฆ
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio โฆ
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boostโฆ
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne โฆ
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of theโฆ
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve โฆ
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:โฆ
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance โฆ
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchโฆ
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung โฆ
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. Forโฆ